Kaynakalar

• WHO. World Drug Report 2010. New York, NY World Health Organization; 2010.
   Google Scholar
• Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA 2004; 291(17): 2114–21.
   PubMed Web of Science ®Google Scholar
• KOM. Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı. http://www.kom.gov.tr/Tr/.
   Google Scholar
• Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376(9752): 1558–65.
   PubMed Web of Science ®Google Scholar
• Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr 2006; 28(2): 153–7.
   PubMed Web of Science ®Google Scholar
• Gaoni Y, Mechoulam R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 1971; 93(1): 217–24.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47 (Suppl 1): S345–S58.
   PubMed Web of Science ®Google Scholar
• Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 2009; 60(2): 77–84.
   Web of Science ®Google Scholar
• Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006; 46: 101–122.
   PubMed Web of Science ®Google Scholar
• Hall W, Pacula, R. Cannabis use and dependence. Public health and public policy. Cambridge: Cambridge University Press; 2003.
   Google Scholar
• DEA. Controlled Substance Schedules. http://www.deadiversion.usdoj.gov/schedules/index.html#list. Accessed 10/30/11.
   Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370(9584): 319–28.
   PubMed Web of Science ®Google Scholar
• Grotenhermen F. Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential. New York Haworth Press; 2002.
   Google Scholar
• Elphick MR, Egertova M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2001; 356(1407): 381–408.
   PubMed Web of Science ®Google Scholar
• Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol 2011; 72(5): 735–44.
   PubMed Web of Science ®Google Scholar
• Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003; 3(10): 745–55.
   PubMed Web of Science ®Google Scholar
• Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323(7303): 16–21.
   PubMed Web of Science ®Google Scholar
• Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 2005; 29(4): 358–67.
   PubMed Web of Science ®Google Scholar
• Croxford JL, Miller SD. Towards cannabis and cannabinoid treatment of multiple sclerosis. Drugs Today (Barc) 2004; 40(8): 663–76.
   Google Scholar
• Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, et al. Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993; 27(7–8): 827–31.
   PubMed Web of Science ®Google Scholar
• Gieringer D, Rosenthal E, Carter GT. Marijuana Medical Handbook: Practical Guide to Therapeutic Uses of Marijuana: Quick American; 2008.
   Google Scholar
• Denson TF, Earleywine M. Decreased depression in marijuana users. Addict Behav 2006; 31(4): 738–42.
   Web of Science ®Google Scholar
• Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoactive Drugs 1998; 30(2): 171–7.
   PubMed Web of Science ®Google Scholar
• The La Guardia Committee Report http://www.druglibrary.org/schaffer/library/studies/lag/lagmenu.htm, 1944. Accessed on 10/30/11.
   Google Scholar
• Haller J, Bakos N, Szirmay M, Ledent C, Freund TF. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 2002; 16(7): 1395–8.
   PubMed Web of Science ®Google Scholar
• Grinspoon L, Bakalar JB. Marijuana: The Forbidden Medicine. New Haven, CT: Yale University; 1997.
   Google Scholar
• Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000; 48(6): 477–85.
   PubMed Web of Science ®Google Scholar
• Lagerberg TV, Sundet K, Aminoff SR, Berg AO, Ringen PA, Andreassen OA, et al. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2011; 261(6): 397–405.
   PubMed Web of Science ®Google Scholar
• Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 2008; 13(2): 264–75.
   Web of Science ®Google Scholar
• Crippa JA, Zuardi AW, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 2009; 24(7): 515–23.
   PubMed Web of Science ®Google Scholar
• MAPS. US Marijuana PTSD Study. http://www.maps.org/research/mmj/ accessed on 10/30/11.
   Google Scholar
• Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs 2011; 43(2): 128–35.
   Google Scholar
• Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol Biochem Behav 2011; 98(1): 21–7.
   PubMed Web of Science ®Google Scholar
• Petrosino S, Di Marzo V. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs 2011; 11(1): 51–62.
   Google Scholar
• Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 2011; 110(2): 604–10.
   Web of Science ®Google Scholar
• Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Funderburk FR, Cadet JL, et al. Sleep disturbance in heavy marijuana users. Sleep 2008; 31(6): 901–8.
   PubMed Web of Science ®Google Scholar
• Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51(4): 273–9.
   PubMed Web of Science ®Google Scholar
• Mathers DC, Ghodse AH, Caan AW, Scott SA. Cannabis use in a large sample of acute psychiatric admissions. Br J Addict 1991; 86(6): 779–84.
   PubMedGoogle Scholar
• Suvisaari JM, Haukka JK, Tanskanen AJ, Lonnqvist JK. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch Gen Psychiatry 1999; 56(8): 733–40.
   Google Scholar
• Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr 1992; (Suppl): S1–S97.
   Google Scholar
• Rowe BH, Therrien S, Johnson C, Sahai VS, Bota GW. Regional variations of northern health: the epidemic of fatal trauma in northeastern Ontario. Can J Public Health 1995; 86(4): 249–54.
   Web of Science ®Google Scholar
• Grover S, Basu, D. Cannabis and Psychopathology: Update 2004. Indian Journal of Psychiatry 2004; 46(4): 299–309.
   Google Scholar
• Ellison K. Medical Marijuana: No Longer Just for Adults New York Times; 2009. http://www.nytimes.com/2009/11/22/health/22sfmedical.html accessed on 10/30/11.
   Google Scholar
• Jager G, Ramsey NF. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev 2008; 1(2): 114–23.
   PubMedGoogle Scholar
• Snelders S, Kaplan C, Pieters T. On cannabis, chloral hydrate, and career cycles of psychotropic drugs in medicine. Bull Hist Med 2006; 80(1): 95–114.
   Web of Science ®Google Scholar
• Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, et al. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. PLoS One 2011; 6(8): 23690.
   Web of Science ®Google Scholar
• Jacobus J, McQueeny T, Bava S, Schweinsburg BC, Frank LR, Yang TT, et al. White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicol Teratol 2009; 31(6): 349–55.
   PubMed Web of Science ®Google Scholar
• Ramesh D, Ross GR, Schlosburg JE, et al. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice. J Pharmacol Exp Ther 2011; 339(1): 173–85.
   PubMed Web of Science ®Google Scholar
• Arendt M, Munk-Jorgensen P. Heavy cannabis users seeking treatment-prevalence of psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol 2004; 39(2): 97–105.
   PubMed Web of Science ®Google Scholar
• Chen CY, Wagner FA, Anthony JC. Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 2002; 37(5): 199–206.
   PubMed Web of Science ®Google Scholar
• Van Ours JC, Williams J. Cannabis use and mental health problems. Vol 7384: CEPR Discussion Paper; 2009.
   Google Scholar
• American Psychiatric Association. Task Force on D-I. Diagnostic and statistical manual of mental disorders: DSM-IV-TR: American Psychiatric Association; 2000.
   Google Scholar
• American Medical Association (AMA). Use of Cannabis for Medicinal Purposes 2009.
   Google Scholar
• American College of Physicians. Supporting Research into the Therapeutic Role of Marijuana. Philadelphia 2008.
   Google Scholar
• Food and Drug Administration (FDA). Inter-Agency Advisory Regarding Claims That Smoked Marijuana Is a Medicine; 2006.
   Google Scholar
• Rhode Island Medical Marijuana Act. http://www.health.ri.gov/healthcare/medicalmarijuana/index.php. Accessed 10/30/11, 2011.
   Google Scholar
• The Colorado Medical Marijuana Registry. http://www.cdphe.state.co.us/hs/medicalmarijuana/.
   Google Scholar
• D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 2009; 259(7): 413–31.
   PubMed Web of Science ®Google Scholar
• Yanık M. İlk esrar kullanımında oluşan panik atak: İki olgu nedeniyle esrar kullanımı ile panik bozukluk ilişkisi. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2002; 12 (4): 191–3.
   Google Scholar
• Ferguson A. The United States of Amerijuana. Time Magazine; 2010. http://www.time.com/time/magazine/article/0,9171,2030925,00.html accessed on 10/30/11.
   Google Scholar
• Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 24 2007; 27(43): 11700–11.
   Google Scholar
• Haney M. Effects of smoked marijuana in healthy and HIV + marijuana smokers. J Clin Pharmacol 2002; 42(Suppl 11): S34–S40.
   Web of Science ®Google Scholar